Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» cancer
cancer
How Bioinformatics Could Find The Next Breakthrough Cancer Drug
Forbes
Wed, 08/12/15 - 10:51 am
bioinformatics
cancer
cancer immunotherapy
Once Disparaged, 'Me-Too' Drugs Crucial For Lower Costs Of Cholesterol, Hepatitis C And Cancer Drugs
Forbes
Tue, 08/11/15 - 09:56 am
me-too drugs
drug pricing
hepatitis C
cancer
Sprint licenses tumor metabolism program to Bayer in €190M deal
Fierce Biotech
Wed, 07/29/15 - 09:53 pm
Sprint Bioscience
Bayer
R&D
cancer
Biotech Clovis Oncology raising $275 million for new cancer drugs
Bizjournals.com
Wed, 07/8/15 - 09:48 am
Clovis Oncology
rucaparib
cancer
3 Experimental Cancer Drugs Investors Should Be Closely Watching
Motley Fool
Fri, 07/3/15 - 11:20 am
cancer
JCAR015
Juno Therapeutics
Celgene
Celldex Therapeutics
Rentiga
Geron
imetelstat
Novartis playing catch-up in cancer? Not us, says top oncology exec
Fierce Pharma Marketing
Wed, 06/24/15 - 08:35 am
Novartis
oncology
cancer
immuno-oncology
Cancer Therapy Boosts Appeal of Juno, Kite as Targets: Real M&A
Bloomberg
Wed, 06/24/15 - 08:29 am
Juno Therapeutics
Kite Pharma
M&A
cancer
CAR-T
Doctors propose tool to help gauge the value of cancer drugs
Yahoo/AP
Tue, 06/23/15 - 10:36 am
physicians
cancer
Hot Atara snags licensing deal with leading cancer center
Bizjournals.com
Mon, 06/15/15 - 09:54 am
Atara
cancer
Memorial Sloan Kettering
AstraZeneca R&D executive Morrison to lead cancer firm Syndax
Yahoo/Reuters
Mon, 06/15/15 - 09:28 am
AstraZeneca
R&D
cancer
Briggs Morrison
Syndax
Eyeing buyout, Celgene paying $105M to partner on Lycera's anti-cancer T cell tech
Fierce Biotech
Tue, 06/9/15 - 12:00 pm
Celegene
Lycera
M&A
cancer
T-cells
Will Big Pharma Cancer Drug Collaborations Set The Stage For Lower Drug Costs?
Forbes
Mon, 06/1/15 - 12:20 pm
cancer
Big Pharma
drug pricing
Novartis, Celgene meds take the biggest shares of cancer drug spending
Fierce Pharma
Thu, 05/28/15 - 01:56 pm
Novartis
Celgene
cancer
Post-swap Novartis preps cancer drug R&D road show
Fierce Biotech
Wed, 05/27/15 - 11:26 am
Novartis
R&D
cancer
Tafinlar
Mekinist
GSK
ASCO
CEO of cancer vax rising star Bavarian Nordic: We are not for sale
BioPharma Dive
Wed, 05/27/15 - 11:07 am
M&A
cancer
cancer vaccines
Bavarian Nordic
Paul Chaplin
The FierceBiotech panel: Top research execs tackle the fast-changing field of cancer drug R&D
Fierce Biotech
Mon, 05/18/15 - 10:04 pm
biotech
cancer
R&D
10 Important Checkpoint Inhibitor Cancer Drug Abstracts from ASCO '15
TheStreet.com
Fri, 05/15/15 - 11:05 am
ASCO
cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Roche
Genentech
MPDL3280A
MEDI4736
AstraZeneca
ASCO cancer research data drop: What to watch
CNBC
Wed, 05/13/15 - 12:18 pm
ASCO
oncology
cancer
Merck
Bristol-Myers Squibb
AstraZeneca
Juno Therapeutics
CAR-T
Ibrance
Pfizer
elotuzumab
Opdivo
Keytruda
Is Novartis an Up-and-Coming Oncology Powerhouse?
Yahoo/Market Realist
Wed, 05/6/15 - 08:51 am
Novartis
oncology
cancer
Global cancer drug spending hits $100 billion in 2014-IMS Health
Yahoo/Reuters
Tue, 05/5/15 - 08:41 am
cancer
drug spending
Pages
« first
‹ previous
…
41
42
43
44
45
46
47
48
49
…
next ›
last »